Comparison of real-life data of abiraterone acetate and enzalutamide in metastatic castration-resistant prostate cancer

dc.date.accessioned	2023-03-06T07:31:41Z
dc.date.available	2023-03-06T07:31:41Z
dc.date.issued	2021
dc.identifier.citation	Sci Rep. 2021 Jul 8;11(1):14131. doi: 10.1038/s41598-021-93659-x.
dc.identifier.uri	https://hdl.handle.net/20.500.12619/99884
dc.relation.isversionof	10.1038/s41598-021-93659-x
dc.relation.isversionof	10.1038/s41598-021-93659-x
dc.title	Comparison of real-life data of abiraterone acetate and enzalutamide in metastatic castration-resistant prostate cancer
dc.relation.journal	Sci Rep
dc.identifier.doi	10.1038/s41598-021-93659-x
dc.contributor.author	Demirci A
dc.contributor.author	Demirci A
dc.contributor.author	Bilir C
dc.contributor.author	Gülbağcı B
dc.contributor.author	Hacıbekiroğlu İ
dc.contributor.author	Bayoğlu İV
dc.contributor.author	Bilgetekin İ
dc.contributor.author	Koca S